Patent details

EP1708717 Title: Atomoxetine for treatment of allergic rhinitis and asthma

Basic Information

Publication number:
EP1708717
PCT Application Number:
PCT/US/2004/024125
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047792585
PCT Publication Number:
WO/2005/011583
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Atomoxetine for treatment of allergic rhinitis and asthma
French Title of Invention:
L'atomoxétine pour le traitement de la rhinite allergique et l'asthme
German Title of Invention:
Atomoxetin zur Behandlung von allergischer Rhinitis und Asthma
SPC Number:

Dates

Filing date:
27/07/2004
Grant date:
05/10/2011
EP Publication Date:
05/10/2011
PCT Publication Date:
10/02/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/10/2006
EP B1 Publication Date:
05/10/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/07/2012
Expiration date:
27/07/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/07/2004
 
 

Name:
Dunaway Leslie Joe
Address:
2016 Fairway Vista Drive, Louisville, KY 40245, United States (US)

Inventor

Name:
Dunaway Leslie Joe
Address:
United States (US)

Priority

Priority Number:
490644 P
Priority Date:
28/07/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/138;
Filing date Document type Number of pages